Default company panoramic image

BOSS Translational Medicine, Ltd.

BOSS is a R&D company focusing on autoimmune disease and lymphoma therapies and vaccination enhancement, utilizing the IL-14 gene.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Buffalo, NY, USA
  • Currency USD
  • Founded July 2012
  • Employees 4

Company Summary

Boss Translational Medicine, Ltd. performs cutting-edge research for clinical products based on technologies that are proprietary and for which it has unique expertise. It develops new tools for the treatment of cancers and adapts them for the management of defined autoimmune diseases. It plans to also create novel technology to enhance the efficiency of all vaccines. Various companies will be sought to help bring these products to market.


  • Default avatar
    Julian L. Ambrus, Jr., MD
    President & Founder

    Dr. Ambrus has 30+ years of work in immunology and rheumatology. His work at the NIH, Washington University in St. Louis and the State University of New York at Buffalo served as the foundation for BOSS Translational Medicine, Ltd . He has served as a consultant and done collaborative projects with Amgen, Centacor, Monsanto, CellGenesys. Genentech, Immco and Nicox. He holds multiple patents and has published over 80 papers in top journals.

  • Default avatar
    Sarah M. Ambrus
    Chied Executive Officer

    Mrs. Ambrus was the former Vice President of Planning for Kaleida Health, with fifteen years of experience in strategic planning, operational management and capital financing. Mrs. Ambrus was a top leader in four hospital mergers. She has an MBA with a triple concentration from the Simon School of Business, University of Rochester and is certified in corporate start-ups. She was recognized by Business First for WNY's top “Forty Under Forty".

  • Default avatar
    Jeffrey C. Magavern
    Chief Legal Counsel

    Mr. Magavern has been a NY licensed attorney since 1990. He is admitted to Federal Court and Bankruptcy Court. His Jurist Doctorate is from The State University of NY at Buffalo. He is the managing partner of his private practice, Magavern & Loretto, P.C. His practice concentrates in real property, corporate law, wills, estates, bankruptcy and criminal law. He has counseled Dr. Ambrus on intellectual property protection for his work.

  • Default avatar
    Long Shen
    Senior Scientist

    Dr. Shen is a graduate of Xiamen University (China) and the State University of NY at Buffalo. He has extensive training in biochemistry, molecular biology and cancer biology. Under Dr. Ambrus, Dr. Shen has helped to develop a novel animal model to study the pathophysiology of Sjogren’s disease and B-cell lymphomas, resulting in early diagnosis bio-markers for Sjogren’s Disease. Dr. Shen has published multiple papers and is a national speaker.


  • Default avatar
    Jeffrey C. Magavern, Esq.
    Default avatar
    Gaines Kriner Elliott, LLP